These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19464746)

  • 1. Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus.
    Gomes MB; Cobas RA; Nunes E; Castro-Faria-Neto HC; da Matta MF; Neves R; Tibiriçá E
    Diabetes Res Clin Pract; 2009 Jul; 85(1):61-8. PubMed ID: 19464746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum platelet-activating factor acetylhydrolase activity: a novel potential inflammatory marker in type 1 diabetes.
    Gomes MB; Cobas RA; Nunes E; Nery M; Castro-Faria-Neto HC; Tibiriçá E
    Prostaglandins Other Lipid Mediat; 2008 Dec; 87(1-4):42-6. PubMed ID: 18718550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
    Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
    Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of IL-12 concentration, PAF-AH, and PLA(2) activity in patients with type 1 diabetes treated with intensive insulin therapy.
    Wegner M; Araszkiewicz A; Pioruńska-Mikołajczak A; Zozulińska-Ziółkiewicz D; Wierusz-Wysocka B; Pioruńska-Stolzmann M
    Clin Biochem; 2009 Nov; 42(16-17):1621-7. PubMed ID: 19651120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor acetylhydrolase activity in patients with chronic stable angina (preliminary results).
    Tănăseanu C; Moldoveanu E; Kosaka T; Neagu M; Tănăseanu S; Popescu M; Tamşulea I; Urban A
    Rom J Intern Med; 2003; 41(2):145-52. PubMed ID: 15526499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.
    Caini P; Guerra CT; Giannini C; Giannelli F; Gragnani L; Petrarca A; Solazzo V; Monti M; Laffi G; Zignego AL
    J Viral Hepat; 2007 Jan; 14(1):22-8. PubMed ID: 17212640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine platelet-activating factor acetylhydrolase (PAF-AH) activity related to fertility.
    Turk R; Juretić D; Geres D; Bacić G; Milesević M; Flegar-Mestrić Z; Turk N; Svetina A
    Anim Reprod Sci; 2008 May; 105(3-4):344-53. PubMed ID: 17442508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in inflammatory cardiovascular risk markers in hyperlipidemic diabetic patients treated with fenofibrate.
    Wu TJ; Ou HY; Chou CW; Hsiao SH; Lin CY; Kao PC
    Ann Clin Lab Sci; 2007; 37(2):158-66. PubMed ID: 17522372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis.
    Vadas P; Gold M; Perelman B; Liss GM; Lack G; Blyth T; Simons FE; Simons KJ; Cass D; Yeung J
    N Engl J Med; 2008 Jan; 358(1):28-35. PubMed ID: 18172172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents.
    Syrenicz A; Garanty-Bogacka B; Syrenicz M; Gebala A; Walczak M
    Neuro Endocrinol Lett; 2006 Aug; 27(4):453-8. PubMed ID: 16892000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
    Ninio E; Tregouet D; Carrier JL; Stengel D; Bickel C; Perret C; Rupprecht HJ; Cambien F; Blankenberg S; Tiret L
    Hum Mol Genet; 2004 Jul; 13(13):1341-51. PubMed ID: 15115767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered distribution of plasma platelet-activating factor acetylhydrolase between high-density lipoprotein and low-density lipoprotein in patients with polycystic ovary syndrome.
    Fan P; Liu HW; Wan DH; Li Y; Song Q; Bai H
    Fertil Steril; 2009 Dec; 92(6):2054-7. PubMed ID: 19596311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and fetal plasma platelet-activating factor acetylhydrolase activity and distribution in pre-eclampsia.
    Fan P; Liu XH; He GL; Zhang S; Zhang JX; Bai H
    Pediatr Res; 2012 Oct; 72(4):426-31. PubMed ID: 22797139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample.
    Raison CL; Lin JM; Reeves WC
    Brain Behav Immun; 2009 Mar; 23(3):327-37. PubMed ID: 19111923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus.
    Mojahedi MJ; Bonakdaran S; Hami M; Sheikhian MR; Shakeri MT; Aiatollahi H
    Iran J Kidney Dis; 2009 Jan; 3(1):12-6. PubMed ID: 19377253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between adiponectin, inflammatory markers and obesity in type 2 diabetic and non-diabetic Trinidadians.
    Nayak S; Soon SQ; Kunjal R; Ramadoo R; Baptiste O; Persad J; Temull V; Diptee L; Balgobin S
    Arch Physiol Biochem; 2009 Feb; 115(1):28-33. PubMed ID: 19267280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor acetylhydrolase (PAF-AH) activity in patients with type 1 diabetes mellitus.
    de Castro SH; Faria Neto HC; Gomes MB
    Arq Bras Cardiol; 2007 Feb; 88(2):179-84. PubMed ID: 17384835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma high sensitivity C-reactive protein and its relationship with cytokine levels in children with newly diagnosed type 1 diabetes and ketoacidosis.
    Karavanaki K; Kakleas K; Georga S; Bartzeliotou A; Mavropoulos G; Tsouvalas M; Vogiatzi A; Papassotiriou I; Karayianni C
    Clin Biochem; 2012 Nov; 45(16-17):1383-8. PubMed ID: 22584003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation.
    Okamura K; Miura S; Zhang B; Uehara Y; Matsuo K; Kumagai K; Saku K
    Circ J; 2007 Feb; 71(2):214-9. PubMed ID: 17251670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.